Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling

Yunping Qiu, M. Su, Y. Liu, M. Chen, J. Gu, J. Zhang, W. Jia

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

A new combined gas chromatography and mass spectrometry (GC-MS) method has been developed suitable for the urine sample treatment in aqueous phase with ethyl chloroformate (ECF) derivatization agents. The method has been extensively optimized and validated over a broad range of different compounds and urine samples. Analysis of test metabolite derivatives, containing spiked standards, or rat urine exhibited acceptable linearity, satisfactory intra-batch precision (repeatability) and stability, relative standard deviations (R.S.D.) less than 10 and 15% within 48 h, respectively. The quantification limits were 150-300 pg on column for most metabolites. Recovery of several representative compounds, at different concentrations, ranged from 70 to 120%, with R.S.D. better than 10% for rat urine. We were able to generally eliminate potentially confounding variables such as medium complexity, different urea concentrations, and/or derivatization procedure variability. Metabonomic profiling of 1,2-dimethylhydrazine (DMH)-induced precancerous colon rat urine using GC-MS with ECF derivatization was performed to evaluate the proposed method. The analytical variation of the method was smaller than the biological variation in the rat urine samples, proving the suitability of the method to analyze differences in the metabonome of a living system with perturbed metabolic network. Thus, the proposed GC-MS analytical method is reliable to analyze a large variety of metabolites and can be used to investigate human pathology including disease onset, progression, and mortality.

Original languageEnglish (US)
Pages (from-to)277-283
Number of pages7
JournalAnalytica Chimica Acta
Volume583
Issue number2
DOIs
StatePublished - Feb 5 2007
Externally publishedYes

Fingerprint

Metabolomics
Gas chromatography
urine
Gas Chromatography-Mass Spectrometry
Mass spectrometry
Rats
gas chromatography
Metabolites
mass spectrometry
Urine
metabolite
1,2-Dimethylhydrazine
Pathology
Urea
Confounding Factors (Epidemiology)
linearity
Derivatives
Recovery
urea
Metabolic Networks and Pathways

Keywords

  • Aqueous phase
  • Ethyl chloroformate
  • Gas chromatography and mass spectrometry
  • Metabonomic profiling

ASJC Scopus subject areas

  • Biochemistry
  • Analytical Chemistry
  • Spectroscopy
  • Environmental Chemistry

Cite this

Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling. / Qiu, Yunping; Su, M.; Liu, Y.; Chen, M.; Gu, J.; Zhang, J.; Jia, W.

In: Analytica Chimica Acta, Vol. 583, No. 2, 05.02.2007, p. 277-283.

Research output: Contribution to journalArticle

Qiu, Yunping ; Su, M. ; Liu, Y. ; Chen, M. ; Gu, J. ; Zhang, J. ; Jia, W. / Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling. In: Analytica Chimica Acta. 2007 ; Vol. 583, No. 2. pp. 277-283.
@article{c0a84eb62eb74d10a1e93c32e7c495d8,
title = "Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling",
abstract = "A new combined gas chromatography and mass spectrometry (GC-MS) method has been developed suitable for the urine sample treatment in aqueous phase with ethyl chloroformate (ECF) derivatization agents. The method has been extensively optimized and validated over a broad range of different compounds and urine samples. Analysis of test metabolite derivatives, containing spiked standards, or rat urine exhibited acceptable linearity, satisfactory intra-batch precision (repeatability) and stability, relative standard deviations (R.S.D.) less than 10 and 15{\%} within 48 h, respectively. The quantification limits were 150-300 pg on column for most metabolites. Recovery of several representative compounds, at different concentrations, ranged from 70 to 120{\%}, with R.S.D. better than 10{\%} for rat urine. We were able to generally eliminate potentially confounding variables such as medium complexity, different urea concentrations, and/or derivatization procedure variability. Metabonomic profiling of 1,2-dimethylhydrazine (DMH)-induced precancerous colon rat urine using GC-MS with ECF derivatization was performed to evaluate the proposed method. The analytical variation of the method was smaller than the biological variation in the rat urine samples, proving the suitability of the method to analyze differences in the metabonome of a living system with perturbed metabolic network. Thus, the proposed GC-MS analytical method is reliable to analyze a large variety of metabolites and can be used to investigate human pathology including disease onset, progression, and mortality.",
keywords = "Aqueous phase, Ethyl chloroformate, Gas chromatography and mass spectrometry, Metabonomic profiling",
author = "Yunping Qiu and M. Su and Y. Liu and M. Chen and J. Gu and J. Zhang and W. Jia",
year = "2007",
month = "2",
day = "5",
doi = "10.1016/j.aca.2006.10.025",
language = "English (US)",
volume = "583",
pages = "277--283",
journal = "Analytica Chimica Acta",
issn = "0003-2670",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling

AU - Qiu, Yunping

AU - Su, M.

AU - Liu, Y.

AU - Chen, M.

AU - Gu, J.

AU - Zhang, J.

AU - Jia, W.

PY - 2007/2/5

Y1 - 2007/2/5

N2 - A new combined gas chromatography and mass spectrometry (GC-MS) method has been developed suitable for the urine sample treatment in aqueous phase with ethyl chloroformate (ECF) derivatization agents. The method has been extensively optimized and validated over a broad range of different compounds and urine samples. Analysis of test metabolite derivatives, containing spiked standards, or rat urine exhibited acceptable linearity, satisfactory intra-batch precision (repeatability) and stability, relative standard deviations (R.S.D.) less than 10 and 15% within 48 h, respectively. The quantification limits were 150-300 pg on column for most metabolites. Recovery of several representative compounds, at different concentrations, ranged from 70 to 120%, with R.S.D. better than 10% for rat urine. We were able to generally eliminate potentially confounding variables such as medium complexity, different urea concentrations, and/or derivatization procedure variability. Metabonomic profiling of 1,2-dimethylhydrazine (DMH)-induced precancerous colon rat urine using GC-MS with ECF derivatization was performed to evaluate the proposed method. The analytical variation of the method was smaller than the biological variation in the rat urine samples, proving the suitability of the method to analyze differences in the metabonome of a living system with perturbed metabolic network. Thus, the proposed GC-MS analytical method is reliable to analyze a large variety of metabolites and can be used to investigate human pathology including disease onset, progression, and mortality.

AB - A new combined gas chromatography and mass spectrometry (GC-MS) method has been developed suitable for the urine sample treatment in aqueous phase with ethyl chloroformate (ECF) derivatization agents. The method has been extensively optimized and validated over a broad range of different compounds and urine samples. Analysis of test metabolite derivatives, containing spiked standards, or rat urine exhibited acceptable linearity, satisfactory intra-batch precision (repeatability) and stability, relative standard deviations (R.S.D.) less than 10 and 15% within 48 h, respectively. The quantification limits were 150-300 pg on column for most metabolites. Recovery of several representative compounds, at different concentrations, ranged from 70 to 120%, with R.S.D. better than 10% for rat urine. We were able to generally eliminate potentially confounding variables such as medium complexity, different urea concentrations, and/or derivatization procedure variability. Metabonomic profiling of 1,2-dimethylhydrazine (DMH)-induced precancerous colon rat urine using GC-MS with ECF derivatization was performed to evaluate the proposed method. The analytical variation of the method was smaller than the biological variation in the rat urine samples, proving the suitability of the method to analyze differences in the metabonome of a living system with perturbed metabolic network. Thus, the proposed GC-MS analytical method is reliable to analyze a large variety of metabolites and can be used to investigate human pathology including disease onset, progression, and mortality.

KW - Aqueous phase

KW - Ethyl chloroformate

KW - Gas chromatography and mass spectrometry

KW - Metabonomic profiling

UR - http://www.scopus.com/inward/record.url?scp=33846128104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846128104&partnerID=8YFLogxK

U2 - 10.1016/j.aca.2006.10.025

DO - 10.1016/j.aca.2006.10.025

M3 - Article

C2 - 17386556

AN - SCOPUS:33846128104

VL - 583

SP - 277

EP - 283

JO - Analytica Chimica Acta

JF - Analytica Chimica Acta

SN - 0003-2670

IS - 2

ER -